Elevated lipoprotein (a) concentrations are associated with atherothrombotic complications of coronary artery disease. In this study, combined lipid apheresis and lipid-lowering medication was efficacious in reducing extremely high levels of lipoprotein (a), and thus in preventing major adverse coronary events, in patients in whom maximally tolerated doses of medication alone had failed to control events associated with coronary artery disease.
- Beate R Jaeger
- Yvonne Richter
- Dietrich Seidel